Item 1A. Risk Factors
Item
1A. Risk Factors.
You
should carefully consider the factors discussed under the section entitled “Risk Factors” in our most recent Annual Report
on Form 10-K filed with the SEC on March 31, 2026, as such factors could materially affect our business, financial condition, and future
results. The risks described in such annual report are not the only risks that we face. Additional risks and uncertainties not currently
known to us, or that we currently deem to be immaterial, also may have a material adverse impact on our business, financial condition,
or results of operations. There have been no material changes to the risk factors identified in our most recent Annual Report on Form
10-K, other than as set forth below.
Sales of a substantial
number of shares of our common stock, including shares issued or issuable pursuant to our ATM program and upon the conversion or exercise
of our outstanding convertible or exercisable securities, could cause the market price of our common stock to decline.
The sale of a substantial number of shares of our common stock in the
public market, or the perception that such sales may occur, could cause the market price of our common stock to decline. We had 44,538,106
shares of common stock outstanding as of May 14, 2026 (excluding any shares issuable upon the conversion or exercise, as applicable, of
our outstanding Series A senior convertible preferred stock, warrants or stock options). A substantial majority of the outstanding shares
of our common stock are freely tradable without restriction or further registration under the Securities Act, unless such shares are owned
or purchased by “affiliates” as that term is defined in Rule 144 under the Securities Act.
In addition, as of May 14, 2026, there were outstanding (i) 392,500
shares of Series A senior convertible preferred stock convertible into an aggregate of 1,401,786 shares of common stock, (ii) warrants
to purchase an aggregate of 11,683,476 shares of common stock, and (iii) stock options to purchase an aggregate of 8,357,500 shares
of our common stock, of which options to purchase 2,400,000 shares of our common stock were then exercisable. The shares of our common
stock issuable upon conversion or exercise, as applicable, of such securities may be immediately eligible for resale in the open market.
We may also utilize our “at the market” equity offering program pursuant to our at market issuance sales agreement with B.
Riley Securities, Inc. and JonesTrading Institutional Services LLC. Any such sales, or the perception that such sales could occur, could
cause the market price of our common stock to decline and may make it more difficult for us to raise capital in the future.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.